Evidence map›Paper›PMID 32488378›Full record

Trial reportEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2020

Improving quality of life through the routine use of the patient concerns inventory for head and neck cancer patients: baseline results in a cluster preference randomised controlled trial.

Simon N Rogers, Christine Allmark, Fazilet Bekiroglu, Rhiannon Tudor Edwards, Gillon Fabbroni, Robert Flavel, Victoria Highet, Michael W S Ho, Gerald M Humphris, Terry M Jones and 17 more

Abstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Improving quality of life through the routine use of the patient concerns inventory for head and neck cancer patients: main results of a cluster preference randomised controlled trial.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2021
    Trial
  5. Article
  6. The Patient Concerns Inventory in head and neck oncology: a structured review of its development, validation and clinical implications.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Simon N RogersFaculty of Health and Social Care, Edge Hill University, Ormskirk, L39 4QP, UK. simonn.rogers@aintree.nhs.uk.ORCID http://orcid.org/0000-0002-5989-6142
Christine AllmarkLeeds Teaching Hospitals and St James Institute of Oncology, Leeds Dental Institute and Leeds General Infirmary, Leeds, UK.
Fazilet BekirogluLiverpool Head and Neck Centre, Liverpool University Hospital Aintree, Liverpool, UK.
Rhiannon Tudor EdwardsCentre for Health Economics and Medicines Evaluation (CHEME), School of Healthcare Sciences, College of Health and Behavioural Sciences (CoHaBS), Ardudwy Building, Normal Site, Bangor University, Bangor, UK.
Gillon FabbroniLeeds Teaching Hospitals and St James Institute of Oncology, Leeds Dental Institute and Leeds General Infirmary, Leeds, UK.
Robert Flavel, Guildford, UK.
Victoria HighetLiverpool Head and Neck Clinical Trials, Clinical Sciences Building, University Hospital Aintree, Liverpool, UK.
Michael W S HoLeeds Teaching Hospitals and St James Institute of Oncology, Leeds Dental Institute and Leeds General Infirmary, Leeds, UK.ORCID http://orcid.org/0000-0001-9810-3136
Gerald M HumphrisSchool of Medicine, Medical and Biological Sciences, North Haugh, St Andrews, UK.
Terry M JonesLiverpool Head and Neck Centre, University of Liverpool, Cancer Research Centre, 200 London Road, Liverpool, L3 9GA, UK.
Owais KhattakLiverpool Head and Neck Centre, Liverpool University Hospital Aintree, Liverpool, UK.
Jeffrey LancasterLiverpool Head and Neck Centre, Liverpool University Hospital Aintree, Liverpool, UK.
Christopher LohLiverpool Head and Neck Centre, Liverpool University Hospital Aintree, Liverpool, UK.
Derek LoweAstraglobe Ltd, Congleton, Cheshire, UK.
Cher LowiesLiverpool Head and Neck Clinical Trials, Clinical Sciences Building, University Hospital Aintree, Liverpool, UK.
Dominic MacareavyLiverpool Head and Neck Centre, Liverpool University Hospital Aintree, Liverpool, UK.
James MoorLeeds Teaching Hospitals and St James Institute of Oncology, Leeds Dental Institute and Leeds General Infirmary, Leeds, UK.
T K OngLeeds Teaching Hospitals and St James Institute of Oncology, Leeds Dental Institute and Leeds General Infirmary, Leeds, UK.
A PrasaiLeeds Teaching Hospitals and St James Institute of Oncology, Leeds Dental Institute and Leeds General Infirmary, Leeds, UK.
Nicholas RolandLiverpool Head and Neck Centre, Liverpool University Hospital Aintree, Liverpool, UK.
Cherith SempleInstitute of Nursing and Health Research, Ulster University, Shore Road, Newtownabbey, Co. Antrim, BT37 0QB, UK.ORCID http://orcid.org/0000-0002-4560-7637
Llinos Haf SpencerCentre for Health Economics and Medicines Evaluation (CHEME), School of Healthcare Sciences, College of Health and Behavioural Sciences (CoHaBS), Ardudwy Building, Normal Site, Bangor University, Bangor, UK.
Sank TandonLiverpool Head and Neck Centre, Liverpool University Hospital Aintree, Liverpool, UK.
Steven J ThomasOral and Maxillofacial Surgery Department, Bristol University, Lower Maudlin Street, Bristol, UK.
Andrew SchacheLiverpool Head and Neck Centre, Liverpool University Hospital Aintree, Liverpool, UK.
Richard J ShawLiverpool Head and Neck Centre, Liverpool University Hospital Aintree, Liverpool, UK.
Anastasios KanatasLeeds Teaching Hospitals and St James Institute of Oncology, Leeds Dental Institute and Leeds General Infirmary, Leeds, UK.

Funding

Department of Health PB-PG-0215-36047Research for Patient Benefit Programme PB-PG-0215-36047
6 · The paper itself

Abstract

purposeThe main aim of this paper is to present baseline demographic and clinical characteristics and HRQOL in the two groups of the Patient Concerns Inventory (PCI) trial. The baseline PCI data will also be described.

methodsThis is a pragmatic cluster preference randomised control trial with 15 consultant clusters from two sites either 'using' (n = 8) or 'not using' (n = 7) the PCI at a clinic for all of their trial patients. The PCI is a 56-item prompt list that helps patients raise concerns that otherwise might be missed. Eligibility was head and neck cancer patients treated with curative intent (all sites, stage of disease, treatments).

resultsFrom 511 patients first identified as eligible when screening for the multi-disciplinary tumour board meetings, 288 attended a first routine outpatient baseline study clinic after completion of their treatment, median (IQR) of 103 (71-162) days. At baseline, the two trial groups were similar in demographic and clinical characteristics as well as in HRQOL measures apart from differences in tumour location, tumour staging and mode of treatment. These exceptions were cluster (consultant) related to Maxillofacial and ENT consultants seeing different types of cases. Consultation times were similar, with PCI group times taking about 1 min longer on average (95% CL for the difference between means was from - 0.7 to + 2.2 min).

conclusionUsing the PCI in routine post-treatment head and neck cancer clinics do not elongate consultations. Recruitment has finished but 12-month follow-up is still ongoing.

Indexed as

Head and Neck NeoplasmsQuality of LifeHumansNeoplasm StagingReferral and ConsultationSurveys and QuestionnairesCluster preferenceHead and neck cancerHealth-related quality of lifeInterventionPatient concerns inventoryPrompt listRandomised trial

Identifiers

PMID32488378
PMCPMC7647987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.